semaglutide gastric intestinal obstruction lawsuit in louisiana law firm gastrointestinal attorney Ozempic [May 2026 Update] Lawsuit Alleges Ozempic Caused Ileus, – semaglutide gastrointestinal obstruction law firm

Kidney disease end points in a pooled analysis of individual patient-level data from a large clinical trials program of the dipeptidyl peptidase 4 inhibitor linagliptin in type 2 diabetes

It does mean the science is moving toward a broader view of GLP-1s as metabolic regulators, not just obesity drugs

[DOI] [PubMed] [Google Scholar] 509.Renstrom E., Eliasson L., Rorsman P

Lemons (three)

Finally, the major population of TriNetX database is the white population and we excluded distinctions for some racial groups like the Hispanic ethnicity, thus the generalizability of our results may be low especially for the non-white populations considering the existing differences in disease prevalence and healthcare access across groups/ethnicities